Cargando…
Current status and perspectives on vaccine development against dengue virus infection
Dengue virus (DENV) consists of four serotypes in the family Flaviviridae and is a causative agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. DENV is transmitted by mosquitoes, Aedes aegypti and A. albopictus, and is mainly observed in areas where vector mosquitoes live. T...
Autores principales: | Park, Jisang, Kim, Ju, Jang, Yong-Suk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Microbiological Society of Korea
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853353/ https://www.ncbi.nlm.nih.gov/pubmed/35157223 http://dx.doi.org/10.1007/s12275-022-1625-y |
Ejemplares similares
-
Recombinant Protein Mimicking the Antigenic Structure of the Viral Surface Envelope Protein Reinforces Induction of an Antigen-Specific and Virus-Neutralizing Immune Response Against Dengue Virus
por: Kim, Ju, et al.
Publicado: (2023) -
Comparative immunogenicity of preparations of yeast-derived dengue oral vaccine candidate
por: Bal, Jyotiranjan, et al.
Publicado: (2018) -
Evaluation of cell-surface displayed synthetic consensus dengue EDIII cells as a potent oral vaccine candidate
por: Bal, Jyotiranjan, et al.
Publicado: (2018) -
Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity
por: Park, Jisang, et al.
Publicado: (2020) -
Dengue vaccine development: status and future
por: Wilder-Smith, Annelies
Publicado: (2019)